聚乙二醇化重组人酸性成纤维细胞生长因子用于转移性胰腺导管腺癌 - Suppr

Suppr

超能文献

PEGPH20 for metastatic pancreatic ductal adenocarcinoma.

作者信息

Gourd Elizabeth

出版信息

Lancet Oncol. 2018 Feb;19(2):e81. doi: 10.1016/S1470-2045(17)30953-1. Epub 2017 Dec 21.

DOI:10.1016/S1470-2045(17)30953-1

PMID:29276021

Abstract

摘要

相似文献

PEGPH20 for metastatic pancreatic ductal adenocarcinoma.

Lancet Oncol. 2018 Feb;19(2):e81. doi: 10.1016/S1470-2045(17)30953-1. Epub 2017 Dec 21.

HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.

J Clin Oncol. 2018 Feb 1;36(4):359-366. doi: 10.1200/JCO.2017.74.9564. Epub 2017 Dec 12.

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.

Clin Cancer Res. 2016 Jun 15;22(12):2848-54. doi: 10.1158/1078-0432.CCR-15-2010. Epub 2016 Jan 26.

Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma.

J Clin Oncol. 2020 Sep 20;38(27):3185-3194. doi: 10.1200/JCO.20.00590. Epub 2020 Jul 24.

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study.

BMC Cancer. 2021 Nov 3;21(1):1176. doi: 10.1186/s12885-021-08887-1.

A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer.

Redox Biol. 2024 Nov;77:103375. doi: 10.1016/j.redox.2024.103375. Epub 2024 Oct 2.

Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis.

Cancer Chemother Pharmacol. 2020 Mar;85(3):517-523. doi: 10.1007/s00280-019-03983-3. Epub 2019 Nov 5.

Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.

JAMA Surg. 2020 Sep 1;155(9):832-839. doi: 10.1001/jamasurg.2020.2286.

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions.

World J Gastroenterol. 2017 Aug 28;23(32):5875-5886. doi: 10.3748/wjg.v23.i32.5875.

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice.

BMC Cancer. 2016 Sep 2;16(1):709. doi: 10.1186/s12885-016-2671-9.

引用本文的文献

A bibliometric analysis of 16,826 triple-negative breast cancer publications using multiple machine learning algorithms: Progress in the past 17 years.

Front Med (Lausanne). 2023 Feb 8;10:999312. doi: 10.3389/fmed.2023.999312. eCollection 2023.

Targeting Versican as a Potential Immunotherapeutic Strategy in the Treatment of Cancer.

Front Oncol. 2021 Aug 30;11:712807. doi: 10.3389/fonc.2021.712807. eCollection 2021.

Emerging technologies provide insights on cancer extracellular matrix biology and therapeutics.

iScience. 2021 Apr 26;24(5):102475. doi: 10.1016/j.isci.2021.102475. eCollection 2021 May 21.

Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Arch Pharm Res. 2021 Feb;44(2):230-240. doi: 10.1007/s12272-021-01309-7. Epub 2021 Jan 24.

Novel stromal biomarker screening in pancreatic cancer patients using the in vitro cancer-stromal interaction model.

BMC Gastroenterol. 2020 Dec 9;20(1):411. doi: 10.1186/s12876-020-01556-w.

Antifibrotic therapy to normalize the tumor microenvironment.

J Transl Med. 2020 May 20;18(1):207. doi: 10.1186/s12967-020-02376-y.

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy.

Front Mol Biosci. 2020 Jan 31;6:160. doi: 10.3389/fmolb.2019.00160. eCollection 2019.

Critical considerations for targeting colorectal liver metastases with nanotechnology.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1588. doi: 10.1002/wnan.1588. Epub 2019 Sep 30.

Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies.

Int J Mol Sci. 2019 May 7;20(9):2256. doi: 10.3390/ijms20092256.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验